“Don’t underestimate
the whole value chain of CMC"
The ''BpiFrance Health Tech 2021 plan'' highlights
the weakness of execution
in the drug development chain
by emerging biotechs.
In the last few years, several French biotechs
have faced difficulties on these execution issues,
despite their undisputed clinical potential.
WHO WE ARE
3BIOTECH is a fully independent, privately owned, drug development focused company, located in Paris, France, operating all over Europe.
3Biotech offers a premium service focused
on 3 majors pillars in drug development
# Safety # Efficacy # Manufacturability
dedicated to biotechs startups in the long run,
for building a full “Chemistry Manufacturing
and Control” strategy.
3Biotech was founded in 2014 to provide impeccable CMC operations and regulatory records.
Olivier Favre-Bulle, founder and CEO, laid the professional foundation of his career in drug development, CMC and regulatory in the Pharma industry to then move into CDMO/CRO as CEO.
He witnessed how several biotech companies, despite their undeniable clinical potential, encountered difficulties in the execution of the drug development chain. These failures meant that innovative therapies were not reaching the bedsides of patients who desperately needed them.
Driven by bringing the best of science on the market, he decided to put his expertise at the disposal of researchers & entrepreneurs and created 3Biotech.
Today our clients, both start-ups and corporations, as well as the biotech investors, have become our first ambassadors. They recognize how the high quality level of our approach, methodology and support has been essential to them making their drugs and innovative therapies more reliable, and accelerating their time to market.
COMPANY'S
PURPOSE
Bringing a drug to market
is a cross-functional project
We are not a consultancy firm, but an accelerator.
See us as members of your team focused on your performance, able to maintain pharmaceutical industry’s high level standards.
Our drug development approach is based on 3 major pillars
OUR CLIENTS
3Biotech works for companies now considered leaders
in the pharmaceutical industry and health investment funds.
OUR partners
3Biotech collaborates with esteemed partners from the pharmaceutical industry and the healthcare investment sector, including incubator companies and business accelerators.
2022 FIGURES
88
Projects
8
MoLecules
In PHASE 1
3
MoLEcules
In PHASE 2
2
MoLecules
IN PHASE 3
96%
CUSTOMER
SATISFACTION
on execution
"DOES YOUR CMC STRATEGY
MATCH THE VALUE
OF YOUR INNOVATION?"
Never forget : great ideas failed due to bad execution. Beware of shortcuts! "Let’s run as fast as we can” is not an option…
WE ARE YOUR BEST SUPPORT ON THE FIELD
FROM SCIENCE TO FIRST IN HUMAN
CONTACT US
66 avenue des Champs-Élysées, 75008 Paris - France
+ 33 (0)1 76 50 40 45
